MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/1061186x.2025.2611944

Медицинская библиотека · Journal of drug targeting · 2026

Buspirone hydrochloride: a potential regulator of PD-L1 for enhanced antitumor activity in melanoma-bearing mice.

Geng Jiaxin, Wang Kangle, Zhang Sheping, Cheng Xiaofei, Zhang Chifei, Mo Mingyu, Ji Xingchan, Shao Mingguang, Jiang Hanyu, Lei Mengyu, Guo Sheng, Yang Zishan, Zhang Yongxi, Wei Tian, Tian Zhongwei, Ji Yinghua, Zhao Tiesuo, Jia Huijie

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

PD-1/PD-L1 blockade therapy shows good efficacy in melanoma treatment. Yet, most patients still exhibit poor responses. Exploring more effective drugs remains worthwhile. In contrast to developing new drugs which entails a lengthy process, high costs and uncertainties, repurposing old drugs is regarded as a promising and safe method, attracting greater attention. In this study, we evaluated the anti-melanoma effect of buspirone hydrochloride, a novel anti-anxiety drug. The results demonstrated that buspirone hydrochloride effectively restrained cell proliferation and migration and decreased the expression of related proteins p-STAT3, cyclin D1 and MMP2. Significantly, we discovered that buspirone hydrochloride efficiently enhanced the degradation of PD-L1. Further investigations in a melanoma-bearing mouse model showed that buspirone hydrochloride delayed the growth of tumours in tumour-bearing mice, increased apoptosis of tumour cells and inhibited cell proliferation. We found that buspirone hydrochloride treatment increased the ratio of T lymphocytes in the spleen of mice and the infiltration of T lymphocytes in tumour tissues. These findings suggest that buspirone hydrochloride not only plays an anti-melanoma role by directly inhibiting cell proliferation and promoting apoptosis but also enhances the anti-tumour immune response by suppressing PD-L1 expression, thus providing a new alternative for the development of melanoma treatment drugs.

Для цитирования: Geng Jiaxin, Wang Kangle, Zhang Sheping, Cheng Xiaofei, Zhang Chifei, Mo Mingyu, Ji Xingchan, Shao Mingguang, Jiang Hanyu, Lei Mengyu, Guo Sheng, Yang Zishan, Zhang Yongxi, Wei Tian, Tian Zhongwei, Ji Yinghua, Zhao Tiesuo, Jia Huijie. Buspirone hydrochloride: a potential regulator of PD-L1 for enhanced antitumor activity in melanoma-bearing mice.. Journal of drug targeting. 2026. DOI: 10.1080/1061186x.2025.2611944.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.